Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Roche clinches a deal for Ventana ...

January 28, 2008 | A version of this story appeared in Volume 86, Issue 4

After a prolonged takeover battle, Ventana Medical Systems has agreed at last to be acquired by Roche. In July 2007, after five months of trying to negotiate, Roche made a $75-per-share hostile takeover offer that Ventana's management called inadequate. Roche now has sweetened its offer to $89.50 per share, or a total of $3.4 billion. Based in Tucson, Ariz., Ventana produces reagents and instrumentation for the histopathology, or tissue-based, diagnostics market. Roche says the acquisition will broaden its diagnostics business and complement its efforts in oncology.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.